Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Characteristics of cohort by history of cancer (n = 329). | History of Cancer (n = 72) | Without Cancer (n = 257) | p-Value a: On vitamin D c | | | 0.275

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Observational study.

Observational study

Observes exposures and outcomes without assigning the exposure; the subtype is not established here.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

A prospective observational study was conducted in a cohort of 329 hospitalized older adults ≥65 years admitted to the acute medical unit (AMU) of a tertiary hospital.

Source: Abstract.

Participants were recruited by research staff not involved in their usual care.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Pre-Frailty and Frailty in Hospitalized Older Adults: A Comparison Study in People with and without a History of Cancer in an Acute Medical Unit

Observational study · Cancers · 2024

Original publication title

Pre-Frailty and Frailty in Hospitalized Older Adults: A Comparison Study in People with and without a History of Cancer in an Acute Medical Unit

Chad Yixian Han; Raymond Javan Chan; Huah Shin Ng; Yogesh Sharma; Alison Yaxley; Claire Baldwin; Michelle Miller

© 2024 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

Abstract: Simple Summary

A prospective observational study was conducted in a cohort of 329 hospitalized older adults ≥65 years admitted to the acute medical unit (AMU) of a tertiary hospital. Statistical models compared older adults with and without a history of cancer to determine characteristics associated with pre-frailty/frailty and length of hospital stay (LOS). About one-fifth of the cohort had a history of cancer. The prevalence of pre-frailty/frailty among older adults with a history of cancer was 58%. In patients with a history of cancer, pre-frailty/frailty was associated with eight and nine times more likelihood of experiencing polypharmacy and malnutrition, respectively.

The risk of having a longer LOS was 24% higher in older adults with a history of cancer than those without. Further investigations are warranted for improvement to systematic assessments to identify those at risk and provide interventions to meet the complex needs of this vulnerable population.

Source: Simple Summary

Abstract: Abstract

A prospective observational study was conducted in a cohort of older adults ≥65 years (n = 329), admitted to the acute medical unit (AMU) of a tertiary hospital, to describe and compare characteristics including frailty status and clinical outcomes. Multivariable models compared older adults with and without a history of cancer to determine characteristics associated with frailty and pre-frailty. An adjusted Poisson regression model was used to compare the length of hospital stay (LOS) between the two groups. About one-fifth (22%) of the cohort had a history of cancer.

The most common cancer types were prostate (n = 20), breast (n = 13), lung (n = 8) and gastrointestinal (n = 8). There was no difference in the prevalence of pre-frailty/frailty among patients with or without a history of cancer (58% vs. 57%, p > 0.05). Pre-frailty/frailty was associated with polypharmacy (OR 8.26, 95% CI: 1.74 to 39.2) and malnutrition (OR 8.91, 95% CI: 2.15 to 36.9) in patients with a history of cancer. Adjusted analysis revealed that the risk of having a longer LOS was 24% higher in older adults with a history of cancer than those without (IRR 1.24, 95% CI 1.10 to 1.41, p < 0.001).

Clinicians in the AMU should be aware that older adults with a history of cancer have a higher risk of a longer LOS compared to those without.

Source: Abstract
Authors’ abstract

Simple Summary

A prospective observational study was conducted in a cohort of 329 hospitalized older adults ≥65 years admitted to the acute medical unit (AMU) of a tertiary hospital. Statistical models compared older adults with and without a history of cancer to determine characteristics associated with pre-frailty/frailty and length of hospital stay (LOS). About one-fifth of the cohort had a history of cancer. The prevalence of pre-frailty/frailty among older adults with a history of cancer was 58%. In patients with a history of cancer, pre-frailty/frailty was associated with eight and nine times more likelihood of experiencing polypharmacy and malnutrition, respectively.

The risk of having a longer LOS was 24% higher in older adults with a history of cancer than those without. Further investigations are warranted for improvement to systematic assessments to identify those at risk and provide interventions to meet the complex needs of this vulnerable population.

Abstract

A prospective observational study was conducted in a cohort of older adults ≥65 years (n = 329), admitted to the acute medical unit (AMU) of a tertiary hospital, to describe and compare characteristics including frailty status and clinical outcomes. Multivariable models compared older adults with and without a history of cancer to determine characteristics associated with frailty and pre-frailty. An adjusted Poisson regression model was used to compare the length of hospital stay (LOS) between the two groups. About one-fifth (22%) of the cohort had a history of cancer.

The most common cancer types were prostate (n = 20), breast (n = 13), lung (n = 8) and gastrointestinal (n = 8). There was no difference in the prevalence of pre-frailty/frailty among patients with or without a history of cancer (58% vs. 57%, p > 0.05). Pre-frailty/frailty was associated with polypharmacy (OR 8.26, 95% CI: 1.74 to 39.2) and malnutrition (OR 8.91, 95% CI: 2.15 to 36.9) in patients with a history of cancer. Adjusted analysis revealed that the risk of having a longer LOS was 24% higher in older adults with a history of cancer than those without (IRR 1.24, 95% CI 1.10 to 1.41, p < 0.001).

Clinicians in the AMU should be aware that older adults with a history of cancer have a higher risk of a longer LOS compared to those without.

Publication and source details

Original title: Pre-Frailty and Frailty in Hospitalized Older Adults: A Comparison Study in People with and without a History of Cancer in an Acute Medical Unit

Chad Yixian Han; Raymond Javan Chan; Huah Shin Ng; Yogesh Sharma; Alison Yaxley; Claire Baldwin; Michelle Miller

Cancers · 2024

* Correspondence: chad.han@flinders.edu.au© 2024 by the authors.2024https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Flinders University’s College of Nursing and Health Sciences Research Student Maintenancethe Australian Government Research Training Program ScholarshipFlinders Medical Centre, Southern Adelaide Local Health NetworkThis study is partially supported by Flinders University’s College of Nursing and Health Sciences Research Student Maintenance and the Australian Government Research Training Program Scholarship. In addition, in-kind support for the staff working on this project has been provided by the Flinders Medical Centre, Southern Adelaide Local Health Network. The funder had no role in the design and conduct of the study; the collection, management, analysis and interpretation of the data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T10:59:40.012618+00:00

DOI: 10.3390/cancers16122212 · PMC11201449